Literature DB >> 13291908

Treatment of chronic granulocytic leukemia with myleran.

J LOUIS, L R LIMARZI, W R BEST.   

Abstract

Entities:  

Keywords:  GLYCOLS/therapeutic use; LEUKEMIA, MYELOCYTIC/therapy

Mesh:

Substances:

Year:  1956        PMID: 13291908     DOI: 10.1001/archinte.1956.00250210045003

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN: 0888-2479


× No keyword cloud information.
  7 in total

1.  The chemotherapy of malignant disease.

Authors:  R B SCOTT
Journal:  Br Med J       Date:  1958-01-04

2.  Medullary aplasia in chronic myeloid leukaemia during busulphan therapy.

Authors:  F G HAYHOE; D KOK
Journal:  Br Med J       Date:  1957-12-21

3.  Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients.

Authors:  Yee Chung Cheng; Mariko Takagi; Andrea Milbourne; Richard E Champlin; Naoto T Ueno
Journal:  Oncologist       Date:  2012-01-26

Review 4.  Fertility preservation and management of gonadal failure associated with lymphoma therapy.

Authors:  Simon J Howell; Stephen M Shalet
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

5.  Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy.

Authors:  J H Waxman; Y A Terry; P F Wrigley; J S Malpas; L H Rees; G M Besser; T A Lister
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-04

Review 6.  Chemotherapy and the adult gonad: a review.

Authors:  J Waxman
Journal:  J R Soc Med       Date:  1983-02       Impact factor: 18.000

7.  Busulphan in the treatment of chronic granulocytic leukaemia.

Authors:  J M BRIDGES; D M HAYES; M G NELSON
Journal:  Br J Cancer       Date:  1961-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.